Head to head
Cresud vs 3M
Side-by-side on the measures that matter, with a plain-English read. Full detail: CRESY · MMM
CRESY
Cresud
11.72+0.77%
1-year price shape — +35% over the period
Quant Rating C · 63/100
vs
MMM
3M
161.74-0.23%
1-year price shape — +6% over the period
Quant Rating C · 46/100
1-year performance, rebased to 100
Cresud edges it on the scoreable measures. Cresud has the highest Quant Rating (63); Cresud has done best over the past year (+35%); Cresud trades cheapest on trailing earnings.
| CRESY | MMM | |
|---|---|---|
| Snapshot | ||
| Sector | Conglomerates | Conglomerates |
| Last price | 11.72 | 161.74 |
| Change today | +0.77% | -0.23% |
| 1-year return | +34.9% | +6.3% |
| Market cap | $831.24M | $83.41B |
| 52-week range | 8.38 – 14.21 | 138.02 – 184.09 |
| Valuation | ||
| P/E (TTM) | 6.60 | 28.73 |
| P/E percentile, own 5-yr range | 70th | 88th |
| P/B | 0.87 | 28.26 |
| Dividend yield | 5.23% | 1.87% |
| Profitability & growth | ||
| EPS (TTM) | 1.78 | 6.00 |
| Net profit (TTM) | $126.03M | $3.09B |
| Revenue (TTM) | $1.29T | $25.18B |
| Revenue growth (YoY) | +8.3% | +2.5% |
| Gross margin | 39.0% | 39.4% |
| Operating margin | 17.0% | 20.4% |
| Net margin | 12.9% | 11.9% |
| Free cash flow (TTM) | $5.93B | $3.99B |
| Ownership & sentiment | ||
| Institutional ownership | 44.8% | 76.3% |
| Insider activity (12mo) | 4 buy / 6 sell | 29 buy / 20 sell |
| Short interest (% of float) | 1.3% | 1.9% |
| Analyst consensus | -- | 42% buy / 50% hold / 8% sell (12) |
| Analyst price target | -- | $189 (+17%) |
| StockVane view | ||
| StockVane Quant Rating | C (63) | C (46) |
| Company | ||
| Employees | 2,889 | 60,500 |
| Founded | 1936 | 1902 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.